Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Trevena Inc. (TRVN)
:TRVN
Holding TRVN?
Track your performance easily
TRVN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.13 - $18.52
Previous CloseN/A
Volume2.03K
Average Volume (3M)5.68K
Market Cap
$1.59M
Enterprise Value$27.01M
Total Cash (Recent Filing)$110.60M
Total Debt (Recent Filing)$13.29M
Price to Earnings (P/E)―
Beta0.72
Next Earnings
Mar 13, 2025EPS Estimate
-2.5Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-46.91
Shares Outstanding863,788
10 Day Avg. Volume4,178
30 Day Avg. Volume5,683
Standard Deviation0.27
R-Squared0.04
Alpha-0.07
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)6.99
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap17.04
Enterprise Value/Revenue21.75
Enterprise Value/Gross Profit-16.17
Enterprise Value/Ebitda-1.14
Forecast
1Y Price Target
$5.00Price Target Upside171.74% Upside
Rating ConsensusHold
Number of Analyst Covering2
Trevena News
PremiumCompany Announcements
Trevena Appoints Katrine Sutton as New CFO
PremiumCompany Announcements
Trevena Inc. Reports Q3 2024 Financial Results
PremiumCompany Announcements
Trevena Faces Leadership Changes Amidst Financial Challenges
Options Prices
Currently, No data available
---
Ownership Overview
6.74% Insiders
0.92% Mutual Funds
1.90% Other Institutional Investors
90.45% Public Companies and Individual Investors
TRVN FAQ
What was Trevena Inc.’s price range in the past 12 months?
Trevena Inc. lowest stock price was $1.13 and its highest was $18.52 in the past 12 months.
What is Trevena Inc.’s market cap?
Trevena Inc.’s market cap is $1.59M.
When is Trevena Inc.’s upcoming earnings report date?
Trevena Inc.’s upcoming earnings report date is Mar 13, 2025 which is in 54 days.
How were Trevena Inc.’s earnings last quarter?
Trevena Inc. released its earnings results on Nov 07, 2024. The company reported -$5.79 earnings per share for the quarter, beating the consensus estimate of -$7.75 by $1.96.
Is Trevena Inc. overvalued?
According to Wall Street analysts Trevena Inc.’s price is currently Undervalued.
Does Trevena Inc. pay dividends?
Trevena Inc. does not currently pay dividends.
What is Trevena Inc.’s EPS estimate?
Trevena Inc.’s EPS estimate is -2.5.
How many shares outstanding does Trevena Inc. have?
Trevena Inc. has 863,788 shares outstanding.
What happened to Trevena Inc.’s price movement after its last earnings report?
Trevena Inc. reported an EPS of -$5.79 in its last earnings report, beating expectations of -$7.75. Following the earnings report the stock price went up 13.953%.
Which hedge fund is a major shareholder of Trevena Inc.?
Currently, no hedge funds are holding shares in TRVN
---
Company Description
Trevena Inc.
Trevena, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of innovative treatment options that target and treat diseases affecting the central nervous system, or CNS. The company product pipeline consists of Olinvo, TRV250, and TRV734. Trevena was founded by Robert Joseph Lefkowitz, Scott DeWire, Howard A. Rockman, Jonathan Violin and Erin Whalen on November 9, 2007 and is headquartered in Chesterbrook, PA.
---
TRVN Earnings Call
Q3 2023
0:00 / 0:00
---
Technical Analysis
Ovid Therapeutics
―
ESSA Pharma
―
Xeris Pharmaceuticals
―
Protagonist Therapeutics
―
Durect
―
Evolus
―
---